Biotechnology Notes

Samarth Vijan
Introduction
Biotechnology is a field of science that uses living organisms, biological systems,
or derivatives to develop or create products and technologies to improve human
life and the health of our planet.
Historical Background:
 Ancient Biotechnology: Humans have used microorganisms for
thousands of years to make bread, cheese, yogurt, and wine through
fermentation processes.
 Classical Biotechnology: Involved selective breeding of plants and
animals to enhance desirable traits.
 Modern Biotechnology: Began in the 1970s with genetic engineering
techniques, like recombinant DNA technology, allowing scientists to
directly manipulate an organism’s genome.
Applications:
 Medical Biotechnology:
o Production of vaccines and antibiotics.
o Gene therapy for treating genetic disorders.
o Development of synthetic insulin.
 Agricultural Biotechnology:
o Creation of genetically modified crops to increase yield, resist pests,
and tolerate harsh environments.
o Enhancing nutritional content.
 Environmental Biotechnology:
o Bioremediation (using microorganisms to clean up oil spills or
remove contaminants from water.
o Developing biofuels as sustainable energy sources.
 Industrial Biotechnology:
o Use of enzymes in detergent manufacturing.
o Production of biodegradable plastics.

Genetic Modification (GM)

Definition: Direct manipulation of an organism’s genome using biotechnology.
Purpose:
 To introduce new traits.
 To enhance existing traits.
 To remove unwanted traits.
Techniques:
 Gene Insertion:
o Adding foreign DNA into an organism's genome.
o Example: Adding a gene for pest resistance to crops.
 Gene Deletion:
o Removing or silencing specific genes to eliminate undesirable traits.
o Example: Removing genes causing ripening in tomatoes to extend
shelf life.
 Gene Editing (CRISPR-Cas9):
o A precise method for cutting and editing DNA sequences.
o Example: Correcting genetic mutations responsible for diseases.

Genetic Engineer’s Toolkit:

 Restriction Enzymes:
o Also called molecular scissors.
o Cut DNA at specific sequences, producing sticky or blunt ends.
o Essential for gene splicing and creating recombinant DNA.
 Ligase Enzyme:
o Joins DNA fragments by forming phosphodiester bonds.
o Used to paste the inserted gene into a host genome.
 Vectors:
o Carriers used to transfer genetic material into a host cell.
o Examples: Plasmids (circular DNA molecules in bacteria) and
viruses.
 Polymerase Chain Reaction (PCR):
o Amplifies small DNA samples to create millions of copies.
o Used in gene cloning, DNA fingerprinting, and forensics.
 Gel Electrophoresis:
o Separates DNA fragments by size using an electric current.
o Helps visualize the success of genetic modification experiments.

Genetic Modification Technology in Insulin Production:

 Before GM: Insulin was extracted from animal pancreases (like cows and
pigs). This led to limited supply and allergic reactions in patients.
 Modern Insulin Production:
o Gene Identification: The human insulin gene is identified and
isolated.
o Insertion into Vector: The insulin gene is inserted into a bacterial
plasmid.
o Transformation: The plasmid is introduced into E. coli bacteria.
o Protein Synthesis: As bacteria grow and reproduce, they produce
human insulin.
o Purification: Insulin is extracted, purified, and packaged for
medical use.
 Benefits:
o Scalability: Large quantities can be produced quickly.
o Safety: Reduced risk of allergic reactions.
o Reliability: Steady and controlled supply.
Genetically Modified Organisms (GMOs):
 Genetically Modified Organisms (GMOs) are organisms whose genomes
have been altered using genetic engineering techniques to enhance
specific traits.
 Examples:
o Golden Rice:
 Description: A type of rice that has been genetically
engineered to produce beta-carotene, a precursor of vitamin
A.
 Benefit: Aims to combat vitamin A deficiency, particularly in
developing countries where rice is a staple food.
o Bt Crops:
 Description: Crops such as Bt corn and Bt cotton are
genetically modified to express a protein from the
bacterium Bacillus thuringiensis, which is toxic to certain
pests.
 Benefit: These crops reduce the need for chemical
pesticides, leading to lower production costs and decreased
environmental impact.
 Benefits of GM Crops:
o Increased Yield: GM crops can be engineered for higher
productivity, helping to meet the food demands of a growing
population.
o Disease Resistance: Genetic modifications can make crops more
resilient to diseases and pests, reducing crop losses.
o Improved Nutrition: Enhanced nutritional profiles, such as
increased vitamins and minerals, can help address nutritional
deficiencies in certain populations.
 Risks of GM Crops:
o Allergic Reactions: There is concern that introducing new proteins
into food crops could trigger allergic reactions in sensitive
individuals.
o Gene Transfer to Wild Species: GM crops may crossbreed with
wild relatives, potentially leading to unintended ecological
consequences and the spread of modified traits in natural
populations.
o Corporate Seed Patents: The commercialization of GM crops
often leads to patenting by corporations, raising issues about
farmers' rights, seed sovereignty, and dependency on seed
companies.

Cloning
Plant Cloning (Tissue Culture):
 Micropropagation: A method to grow plants from small tissue samples in
sterile conditions.
 Steps:
o Selection of Explants: Small samples (like a leaf or stem) are
chosen.
 o Sterilization: To eliminate bacteria and fungi.
o Growth Medium: Explants are placed in nutrient-rich agar
containing plant hormones (auxins and cytokinin).
o Callus Formation: Undifferentiated cells grow into a callus.
o Shoot and Root Development: Hormones stimulate the formation
of shoots and roots.
o Transplantation: Plantlets are moved to soil to mature.
 Advantages:
o Rapid Propagation: Produce thousands of identical plants quickly.
o Disease-Free Plants: Grow in sterile environments.
o Conservation: Preserve endangered plant species.

Animal Cloning:
 Nuclear Transfer: he most common method used for cloning animals.
 Steps:
o Nucleus Removal: Nucleus is removed from an egg cell
(enucleation).
o Nuclear Insertion: The nucleus from a somatic cell (e.g., skin cell)
is inserted into the enucleated egg.
o Stimulation: The egg is stimulated using electricity or chemicals to
start division.
o Embryo Development: The embryo develops in vitro.
o Implantation: The embryo is implanted into a surrogate mother.
o Birth: The clone is born, genetically identical to the donor
organism.
 Example: Dolly the Sheep (1996)  Dolly the sheep, born on July 5, 1996,
at the Roslin Institute in Scotland, was the first mammal cloned from an
adult somatic cell. Using somatic cell nuclear transfer (SCNT), scientists
took a cell from a donor sheep's udder (Finn Dorset) and inserted its
nucleus into an enucleated egg from another sheep (Scottish Blackface).
This embryo was implanted into a surrogate mother, a Scottish Blackface
ewe. Dolly's birth showcased the potential of cloning technology and
sparked ethical discussions in biotechnology. She lived until 2003, marking
a significant milestone in genetic research.
 Applications:
o Conservation: Cloning endangered species.
o Research: Creating genetically identical animals for medical
testing.
o Pharming: Producing animals that produce therapeutic proteins.

Ethical Implications
Ethical Implications of Genetic Modification and Cloning:
 Pros:
o Can prevent genetic diseases.
o Increases food production.
o Conserves endangered species.
 Cons:
o May alter ecosystems unpredictably.
 o Raises concerns about "designer babies."
o Risk of clones having health defects.

Ethical Implications of Stem Cell Research:

 Embryonic Stem Cells: Harvested from early-stage embryos, leading to
ethical debates about the moral status of embryos.
 Adult Stem Cells: Less controversial as they come from adult tissues but
are less versatile.
 Induced Pluripotent Stem Cells (iPSCs): Reprogram adult cells into
stem cells, reducing ethical concerns.

Human Genome Project (HGP)

Overview: An international research initiative aimed at mapping and
understanding all the genes of the human species.
Timeline: Launched in 1990 and completed in April 2003.
Goals:
 Identify and sequence the approximately 20,000-25,000 human genes.
 Determine the sequences of the 3 billion DNA base pairs in the human
genome.
 Store and analyse genomic data for future research.
Significance:
 Advanced knowledge of genetic diseases and their causes.
 Enabled the development of new diagnostic tools and therapies.
 Provided a foundation for personalized medicine and genomics.
International Collaboration: Involved scientists from multiple countries,
including the USA, UK, Japan, France, Germany, and China.
Outcomes:
 Creation of the first complete human genome sequence.
 Publication of findings in scientific journals, making data publicly
accessible.
Impacts: Revolutionized biology, medicine, and biotechnology, influencing
research in genetics, evolutionary biology, and anthropology.

3D Tissue and Organ Printing

Definition: 3D tissue and organ printing are techniques for creating biological
structures using bio-inks made of living cells and growth factors.
Models:
 Scaffold-Based:
o Cells grow on biocompatible scaffolds that provide support.
o Commonly used for tissues like bone and cartilage.
 Cell-Based:
o Focuses on printing cells and extracellular matrix directly.
o Suitable for softer tissues, like liver and heart.
Applications:
 Skin Grafts: Custom skin grafts for burn victims.
 Organ Printing: Potential to print organs for transplants.
 Drug Testing: Models for evaluating drug effects and safety.
Challenges:
 Vascularization: Difficulty in creating blood vessel networks.
 Immune Rejection: Risk of the body rejecting printed tissues.

Technology to Treat Genetic Diseases (Gene Therapy)

Definition: Gene therapy is a technique that involves introducing healthy genes
into a patient's cells to correct genetic mutations responsible for disease. This
approach aims to treat or prevent diseases by addressing their underlying
genetic causes.
Types:
 Somatic Gene Therapy:
o Description: Targets non-reproductive (somatic) cells in the body.
o Characteristics: Changes made are not passed on to future
generations, making it a safer option for many conditions.
o Applications: Used for treating diseases like cystic fibrosis,
muscular dystrophy, and certain types of cancer.
 Germline Gene Therapy:
o Description: Alters reproductive cells (sperm and eggs) or early
embryos.
o Characteristics: Changes are inheritable, meaning they can be
passed to future generations. This raises ethical and safety
concerns.
o Applications: Still largely experimental, with debates surrounding
its implications for human evolution and ethics.
 CRISPR-Cas9:
o Description: A revolutionary gene-editing tool that allows precise
modifications of DNA.
o Mechanism: Utilizes a guide RNA to direct the Cas9 enzyme to
specific locations in the genome, where it can cut the DNA and
enable the insertion or deletion of genetic material.
o Applications: Used in various research and clinical settings to fix
mutations, potentially transforming the field of gene therapy.
Examples:
 SCID Treatment:
o Condition: Severe Combined Immunodeficiency (SCID) is a genetic
disorder that severely weakens the immune system.
o Approach: Gene therapy has been used to introduce a functional
copy of the defective gene responsible for SCID, restoring immune
function in affected individuals.
 Sickle Cell Anaemia:
o Condition: A genetic disorder caused by mutations in the
haemoglobin gene, leading to misshaped red blood cells.
o Approach: CRISPR trials are underway to edit the haemoglobin
gene in patients' stem cells, aiming to produce healthy red blood
cells and alleviate symptoms.